The role of radiotherapy in urinary bladder cancer: current status

Int Braz J Urol. 2012 Mar-Apr;38(2):144-53; discussion 153-4. doi: 10.1590/s1677-55382012000200002.

Abstract

The role of radiotherapy (RT) in the treatment of urinary bladder cancer has undergone several modifications along the last decades. In the beginning, definitive RT was used as treatment in an attempt to preserve the urinary bladder; however, the results were poor compared to those of radical surgery. Recently, many protocols have been developed supporting the use of multi-modality therapy, and the concept of organ preservation began to be reconsidered. Although phase III randomized clinical studies comparing radical cystectomy with bladder preservation therapies do not exist, the conservative treatment may present low toxicity and high indexes of complete response for selected patients. The aim of this study was to review the literature on the subject in order to situate RT in the current treatment of urinary bladder cancer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy
  • Carcinoma / radiotherapy*
  • Carcinoma / surgery
  • Cisplatin / therapeutic use
  • Combined Modality Therapy / methods
  • Cystectomy
  • Humans
  • Postoperative Care
  • Preoperative Care
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / radiotherapy*
  • Urinary Bladder Neoplasms / surgery
  • Urinary Incontinence / etiology

Substances

  • Antineoplastic Agents
  • Cisplatin